Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.52
+0.13003.83%
Post-market: 3.50-0.0196-0.56%16:54 EDT
Volume:10.28M
Turnover:35.72M
Market Cap:1.86B
PE:-2.44
High:3.55
Open:3.40
Low:3.39
Close:3.39
52wk High:7.18
52wk Low:2.80
Shares:527.40M
Float Shares:415.00M
Volume Ratio:0.89
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4410
EPS(LYR):-1.4410
ROE:-59.54%
ROA:-27.72%
PB:1.64
PE(LYR):-2.44

Loading ...

Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Borgeson Blake proposes to sell 170,000 shares, with a total value of approximately $588,200.
Feb 25, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $138,400
Feb 18, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Taylor Ben R proposes to sell 13426 shares, with a total value of approximately $41352.08.
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $178,800
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director B. Borgeson proposes to sell 220,000 shares, with a total value of approximately $959.2K.